Rivastigmine in Wernicke-Korsakoff's syndrome: Five patients with rivastigmine showed no more improvement than five patients without rivastigmine
نویسندگان
چکیده
منابع مشابه
Case Report Rivastigmine in Wernicke-korsakoff’s Syndrome: Five Patients with Rivastigmine Showed No More Improvement than Five Patients without Rivastigmine
Aims: To evaluate whether rivastigmine, an achetylcholinesterase inhibitor (AChEl), may be effective in restoring memory in Wernicke-Korsakoff’s syndrome (WKS). Methods: Five patients treated with rivastigmine for a period of 6 months were compared with five matched control patients, who received 6 months’ conventional treatment, but without rivastigmine. Memory tests were administered at basel...
متن کاملRivastigmine in Wernicke-Korsakoff's syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine.
AIMS To evaluate whether rivastigmine, an achetylcholinesterase inhibitor (AChEl), may be effective in restoring memory in Wernicke-Korsakoff's syndrome (WKS). METHODS Five patients treated with rivastigmine for a period of 6 months were compared with five matched control patients, who received 6 months' conventional treatment, but without rivastigmine. Memory tests were administered at basel...
متن کاملRivastigmine (Exelon) for dementia in patients with Parkinson's disease.
OBJECTIVES To study the efficacy of cholinesterase inhibitors in the treatment of dementia in patients with Parkinson's disease (PD). METHODS We treated twenty-eight demented patients with PD openly for 26 weeks with rivastigmine (mean daily dose 7.2 +/- 3.3 mg/day). Baseline scores were compared with those at weeks 12, 26 and after 8 weeks of washout. RESULTS Twenty patients completed 26 w...
متن کاملRivastigmine in Chinese patients with subcortical vascular dementia
BACKGROUND We explored the efficacy and tolerability of rivastigmine among Chinese patients with subcortical vascular dementia. METHODS Forty subjects were randomized to either placebo (n = 20) or rivastigmine (n = 20) in a double-blind 26-week trial. Outcome measures were cognition (mini-mental state examination, frontal assessment battery), neuropsychiatric inventory (NPI), instrumental act...
متن کاملEconomic evaluation of rivastigmine in patients with Parkinson's disease dementia.
BACKGROUND The positive results of a randomised clinical trial of rivastigmine in patients with dementia associated with Parkinson's disease have been published recently. Patient-level healthcare utilisation data were also collected, and this report is the economic evaluation based on these data. OBJECTIVE To determine the cost effectiveness of rivastigmine 3-12 mg/day in patients in whom mil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alcohol and Alcoholism
سال: 2007
ISSN: 0735-0414,1464-3502
DOI: 10.1093/alcalc/agm158